메뉴 건너뛰기




Volumn 34, Issue 2, 2013, Pages 255-261

PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China

Author keywords

Chinese Han population; genetic polymorphisms; pioglitazone; PPAR 2 rs1801282; PTPRD rs17584499; type 2 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PIOGLITAZONE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 84873561818     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.144     Document Type: Article
Times cited : (52)

References (36)
  • 1
    • 0028588691 scopus 로고
    • Relationship between obesity and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins
    • Matsuda A, Kuzuya T. Relationship between obesity and concordance rate for type 2 (non-insulin-dependent) diabetes mellitus among twins. Diabetes Res Clin Pract 1994; 26: 137-43.
    • (1994) Diabetes Res Clin Pract , vol.26 , pp. 137-43
    • Matsuda, A.1    Kuzuya, T.2
  • 2
    • 0033624575 scopus 로고    scopus 로고
    • The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
    • Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
    • (2000) Nat Genet , vol.26 , pp. 76-80
    • Altshuler, D.1    Hirschhorn, J.N.2    Klannemark, M.3    Lindgren, C.M.4    Vohl, M.C.5    Nemesh, J.6
  • 3
    • 0025132245 scopus 로고
    • Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
    • Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-50.
    • (1990) Nature , vol.347 , pp. 645-50
    • Issemann, I.1    Green, S.2
  • 4
    • 0032588487 scopus 로고    scopus 로고
    • PPARgamma, the ultimate thrifty gene
    • Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999; 42: 1033-49.
    • (1999) Diabetologia , vol.42 , pp. 1033-49
    • Auwerx, J.1
  • 5
    • 0031595923 scopus 로고    scopus 로고
    • A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity
    • Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-7.
    • (1998) Nat Genet , vol.20 , pp. 284-7
    • Deeb, S.S.1    Fajas, L.2    Nemoto, M.3    Pihlajamaki, J.4    Mykkanen, L.5    Kuusisto, J.6
  • 6
    • 0345363159 scopus 로고    scopus 로고
    • Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects
    • Hamann A, Munzberg H, Buttron P, Busing B, Hinney A, Mayer H, et al. Missense variants in the human peroxisome proliferator-activated receptor-gamma2 gene in lean and obese subjects. Eur J Endocrinol 1999; 141: 90-2.
    • (1999) Eur J Endocrinol , vol.141 , pp. 90-2
    • Hamann, A.1    Munzberg, H.2    Buttron, P.3    Busing, B.4    Hinney, A.5    Mayer, H.6
  • 7
    • 0345164399 scopus 로고    scopus 로고
    • Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: Identification of a Pro12Ala PPAR gamma 2 missense mutation
    • Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 1997; 241: 270-4.
    • (1997) Biochem Biophys Res Commun , vol.241 , pp. 270-4
    • Yen, C.J.1    Beamer, B.A.2    Negri, C.3    Silver, K.4    Brown, K.A.5    Yarnall, D.P.6
  • 8
    • 23444457610 scopus 로고    scopus 로고
    • Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes
    • Kang ES, Park SY, Kim HJ, Kim CS, Ahn CW, Cha BS, et al. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes. Clin Pharmacol Ther 2005; 78: 202-8.
    • (2005) Clin Pharmacol Ther , vol.78 , pp. 202-8
    • Kang, E.S.1    Park, S.Y.2    Kim, H.J.3    Kim, C.S.4    Ahn, C.W.5    Cha, B.S.6
  • 9
    • 77649214654 scopus 로고    scopus 로고
    • A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese
    • Tsai FJ, Yang CF, Chen CC, Chuang LM, Lu CH, Chang CT, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet 2010; 6: e1000847.
    • (2010) PLoS Genet , vol.6
    • Tsai, F.J.1    Yang, C.F.2    Chen, C.C.3    Chuang, L.M.4    Lu, C.H.5    Chang, C.T.6
  • 10
    • 33750299450 scopus 로고    scopus 로고
    • Protein tyrosine phosphatases: From genes, to function, to disease
    • Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol 2006; 7: 833-46.
    • (2006) Nat Rev Mol Cell Biol , vol.7 , pp. 833-46
    • Tonks, N.K.1
  • 11
    • 16844386333 scopus 로고    scopus 로고
    • Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases
    • Chagnon MJ, Uetani N, Tremblay ML. Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochem Cell Biol 2004; 82: 664-75.
    • (2004) Biochem Cell Biol , vol.82 , pp. 664-75
    • Chagnon, M.J.1    Uetani, N.2    Tremblay, M.L.3
  • 12
    • 34347228957 scopus 로고    scopus 로고
    • Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen
    • Kawase T, Akatsuka Y, Torikai H, Morishima S, Oka A, Tsujimura A, et al. Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen. Blood 2007; 110: 1055-63.
    • (2007) Blood , vol.110 , pp. 1055-63
    • Kawase, T.1    Akatsuka, Y.2    Torikai, H.3    Morishima, S.4    Oka, A.5    Tsujimura, A.6
  • 13
    • 33749005081 scopus 로고    scopus 로고
    • Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988GA: Evidence for modulation of splicing events
    • Toscano C, Klein K, Blievernicht J, Schaeffeler E, Saussele T, Raimundo S, et al. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988GA: evidence for modulation of splicing events. Pharmacogenet Genomics 2006; 16: 755-66.
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 755-66
    • Toscano, C.1    Klein, K.2    Blievernicht, J.3    Schaeffeler, E.4    Saussele, T.5    Raimundo, S.6
  • 14
    • 18144431682 scopus 로고    scopus 로고
    • The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes
    • Kang ES, Park SY, Kim HJ, Ahn CW, Nam M, Cha BS, et al. The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes. Diabetes Care 2005; 28: 1139-44.
    • (2005) Diabetes Care , vol.28 , pp. 1139-44
    • Kang, E.S.1    Park, S.Y.2    Kim, H.J.3    Ahn, C.W.4    Nam, M.5    Cha, B.S.6
  • 15
    • 0034923501 scopus 로고    scopus 로고
    • Peroxisome proliferatoractivated receptor gamma and metabolic disease
    • Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferatoractivated receptor gamma and metabolic disease. Annu Rev Biochem 2001; 70: 341-67.
    • (2001) Annu Rev Biochem , vol.70 , pp. 341-67
    • Willson, T.M.1    Lambert, M.H.2    Kliewer, S.A.3
  • 16
    • 0036872996 scopus 로고    scopus 로고
    • Addressing the insulin resistance syndrome: A role for the thiazolidinediones
    • Zimmet P. Addressing the insulin resistance syndrome: a role for the thiazolidinediones. Trends Cardiovasc Med 2002; 12: 354-62.
    • (2002) Trends Cardiovasc Med , vol.12 , pp. 354-62
    • Zimmet, P.1
  • 17
  • 18
    • 0036072223 scopus 로고    scopus 로고
    • Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients
    • Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2002; 87: 2784-91.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 2784-91
    • Miyazaki, Y.1    Mahankali, A.2    Matsuda, M.3    Mahankali, S.4    Hardies, J.5    Cusi, K.6
  • 19
    • 0036203666 scopus 로고    scopus 로고
    • Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: A retrospective review of randomly selected medical records
    • Boyle PJ, King AB, Olansky L, Marchetti A, Lau H, Magar R, et al. Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in patients with type 2 diabetes mellitus: a retrospective review of randomly selected medical records. Clin Ther 2002; 24: 378-96.
    • (2002) Clin Ther , vol.24 , pp. 378-96
    • Boyle, P.J.1    King, A.B.2    Olansky, L.3    Marchetti, A.4    Lau, H.5    Magar, R.6
  • 20
    • 0033754530 scopus 로고    scopus 로고
    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study the Pioglitazone 001 Study Group
    • Aronoff S, Rosenblatt S, Braithwaite S, Egan JW, Mathisen AL, Schneider RL. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care 2000; 23: 1605-11.
    • (2000) Diabetes Care , vol.23 , pp. 1605-11
    • Aronoff, S.1    Rosenblatt, S.2    Braithwaite, S.3    Egan, J.W.4    Mathisen, A.L.5    Schneider, R.L.6
  • 21
    • 0038746876 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus
    • Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, et al. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. Clin Ther 2003; 25: 1074-95.
    • (2003) Clin Ther , vol.25 , pp. 1074-95
    • Herz, M.1    Johns, D.2    Reviriego, J.3    Grossman, L.D.4    Godin, C.5    Duran, S.6
  • 23
    • 18744401592 scopus 로고    scopus 로고
    • Metabolic efficacy and safety of once-daily pioglitazone monotherapy in patients with type 2 diabetes: A doubleblind, placebo-controlled study
    • Scherbaum WA, Goke B. Metabolic efficacy and safety of once-daily pioglitazone monotherapy in patients with type 2 diabetes: a doubleblind, placebo-controlled study. Horm Metab Res 2002; 34: 589-95.
    • (2002) Horm Metab Res , vol.34 , pp. 589-95
    • Scherbaum, W.A.1    Goke, B.2
  • 24
    • 78649328506 scopus 로고    scopus 로고
    • Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients
    • Huang Q, Yin JY, Dai XP, Wu J, Chen X, Deng CS, et al. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. Eur J Clin Pharmacol 2010; 66: 1207-15.
    • (2010) Eur J Clin Pharmacol , vol.66 , pp. 1207-15
    • Huang, Q.1    Yin, J.Y.2    Dai, X.P.3    Wu, J.4    Chen, X.5    Deng, C.S.6
  • 25
    • 0029016829 scopus 로고
    • An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
    • Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270: 12953-6.
    • (1995) J Biol Chem , vol.270 , pp. 12953-6
    • Lehmann, J.M.1    Moore, L.B.2    Smith-Oliver, T.A.3    Wilkison, W.O.4    Willson, T.M.5    Kliewer, S.A.6
  • 26
    • 0034607051 scopus 로고    scopus 로고
    • Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis
    • Masugi J, Tamori Y, Mori H, Koike T, Kasuga M. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem Biophys Res Commun 2000; 268: 178-82.
    • (2000) Biochem Biophys Res Commun , vol.268 , pp. 178-82
    • Masugi, J.1    Tamori, Y.2    Mori, H.3    Koike, T.4    Kasuga, M.5
  • 27
    • 77955481012 scopus 로고    scopus 로고
    • Common polymorphisms of the peroxisome proliferator-activated receptorgamma (Pro12Ala) and peroxisome proliferator-activated receptorgamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus
    • Hsieh MC, Lin KD, Tien KJ, Tu ST, Hsiao JY, Chang SJ, et al. Common polymorphisms of the peroxisome proliferator-activated receptorgamma (Pro12Ala) and peroxisome proliferator-activated receptorgamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus. Metabolism 2010; 59: 1139-44.
    • (2010) Metabolism , vol.59 , pp. 1139-44
    • Hsieh, M.C.1    Lin, K.D.2    Tien, K.J.3    Tu, S.T.4    Hsiao, J.Y.5    Chang, S.J.6
  • 28
    • 80455160172 scopus 로고    scopus 로고
    • Polymorphism of peroxisome proliferator-activated receptor gamma (PPARgamma) Pro12Ala in the Iranian population: Relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes
    • Namvaran F, Azarpira N, Rahimi-Moghaddam P, Dabbaghmanesh MH. Polymorphism of peroxisome proliferator-activated receptor gamma (PPARgamma) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes. Eur J Pharmacol 2011; 671: 1-6.
    • (2011) Eur J Pharmacol , vol.671 , pp. 1-6
    • Namvaran, F.1    Azarpira, N.2    Rahimi-Moghaddam, P.3    Dabbaghmanesh, M.H.4
  • 29
    • 18344417084 scopus 로고    scopus 로고
    • Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes
    • Bluher M, Lubben G, Paschke R. Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes. Diabetes Care 2003; 26: 825-31.
    • (2003) Diabetes Care , vol.26 , pp. 825-31
    • Bluher, M.1    Lubben, G.2    Paschke, R.3
  • 31
    • 0029417204 scopus 로고
    • The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: Multiple human LAR PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LARinteracting protein LIP.1
    • Pulido R, Serra-Pages C, Tang M, Streuli M. The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LARinteracting protein LIP.1. Proc Natl Acad Sci USA 1995; 92: 11686-90.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 11686-90
    • Pulido, R.1    Serra-Pages, C.2    Tang, M.3    Streuli, M.4
  • 32
    • 0035491792 scopus 로고    scopus 로고
    • Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptorgamma-mediated changes in gene expression
    • Brunmair B, Gras F, Neschen S, Roden M, Wagner L, Waldhausl W, et al. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptorgamma-mediated changes in gene expression. Diabetes 2001; 50: 2309-15.
    • (2001) Diabetes , vol.50 , pp. 2309-15
    • Brunmair, B.1    Gras, F.2    Neschen, S.3    Roden, M.4    Wagner, L.5    Waldhausl, W.6
  • 33
    • 77958039797 scopus 로고    scopus 로고
    • Novel thiazolidinedione derivatives with anti-obesity effects: Dual action as PTP1B inhibitors and PPAR-gamma activators
    • Bhattarai BR, Kafle B, Hwang JS, Ham SW, Lee KH, Park H, et al. Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-gamma activators. Bioorg Med Chem Lett 2010; 20: 6758-63.
    • (2010) Bioorg Med Chem Lett , vol.20 , pp. 6758-63
    • Bhattarai, B.R.1    Kafle, B.2    Hwang, J.S.3    Ham, S.W.4    Lee, K.H.5    Park, H.6
  • 34
    • 30544435421 scopus 로고    scopus 로고
    • Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocintreated diabetic rats
    • Wu Y, Ouyang JP, Wu K, Wang SS, Wen CY, Xia ZY. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocintreated diabetic rats. Br J Pharmacol 2005; 146: 234-43.
    • (2005) Br J Pharmacol , vol.146 , pp. 234-43
    • Wu, Y.1    Ouyang, J.P.2    Wu, K.3    Wang, S.S.4    Wen, C.Y.5    Xia, Z.Y.6
  • 35
    • 70649100416 scopus 로고    scopus 로고
    • Cytochrome P450 2C8 pharmacogenetics: A review of clinical studies
    • Daily EB, Aquilante CL. Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies. Pharmacogenomics 2009; 10: 1489-510.
    • (2009) Pharmacogenomics , vol.10 , pp. 1489-510
    • Daily, E.B.1    Aquilante, C.L.2
  • 36
    • 33745703773 scopus 로고    scopus 로고
    • Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: Potential for interactions with CYP2C8 inhibitors
    • Jaakkola T, Laitila J, Neuvonen PJ, Backman JT. Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. Basic Clin Pharmacol Toxicol 2006; 99: 44-51.
    • (2006) Basic Clin Pharmacol Toxicol , vol.99 , pp. 44-51
    • Jaakkola, T.1    Laitila, J.2    Neuvonen, P.J.3    Backman, J.T.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.